Peter Braun
Overview
Explore the profile of Peter Braun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antwerpen M, Braun P, Beyer W, Aldenkortt D, Seidel M, Grass G
Pathogens
. 2025 Jan;
14(1).
PMID: 39861044
The anthrax pathogen can remain dormant as spores in soil for many years. This applies to both natural foci and to sites of anthropogenic activity such as tanneries, abattoirs, or...
2.
Woodcock B, Braun P, Gasser M, Sly L, Lissner R
Int J Clin Pharmacol Ther
. 2024 Jun;
62(8):377-385.
PMID: 38916486
Background: Treatment of arthritis is carried out using corticosteroids, methotrexate, sulfasalazine-like agents, and TNF-α-blocking agents such as infliximab and adalimumab. The disadvantages of these agents are high-cost, severe side effects...
3.
Braun P, Lookingbill T, Zizzamia B, Hoffman J, Rosner J, Banta D
Geohealth
. 2024 Jun;
8(6):e2023GH000985.
PMID: 38912226
The urban heat island effect exacerbates independent climate change-induced shifts toward longer, stronger, and more frequent heat extremes. Environmental inequity, driven by a history of racially motivated urban planning policies,...
4.
Pandi A, Adam D, Zare A, Trinh V, Schaefer S, Burt M, et al.
Nat Commun
. 2023 Nov;
14(1):7197.
PMID: 37938588
Bioactive peptides are key molecules in health and medicine. Deep learning holds a big promise for the discovery and design of bioactive peptides. Yet, suitable experimental approaches are required to...
5.
Braun P, Raab R, Bugert J, Braun S
ACS Sens
. 2023 Jan;
8(2):630-639.
PMID: 36719711
The emergence of multi-drug-resistant () strains constitutes an enormous threat to global health as multi-drug resistance-associated treatment failure causes high mortality rates in nosocomial infections. Rapid pathogen detection and antibiotic...
6.
Oguz S, Buia A, Albers B, Suna K, Piroski V, Knapp A, et al.
Int J Clin Pharmacol Ther
. 2022 Nov;
60(12):521-529.
PMID: 36331015
Background: A female patient aged 49 years with a rectal adenocarcinoma underwent tumor resection and multiple follow-up surgical operations whilst receiving compassionate therapy with polyvalent immunoglobulins derived from bovine colostrum...
7.
Emslander Q, Vogele K, Braun P, Stender J, Willy C, Joppich M, et al.
Cell Chem Biol
. 2022 Jul;
29(9):1434-1445.e7.
PMID: 35820417
Bacteriophages are potent therapeutics against biohazardous bacteria, which rapidly develop multidrug resistance. However, routine administration of phage therapy is hampered by a lack of rapid production, safe bioengineering, and detailed...
8.
Braun P, Beyer W, Hanczaruk M, Riehm J, Antwerpen M, Otterbein C, et al.
J Clin Microbiol
. 2022 Feb;
60(3):e0229121.
PMID: 35195442
The zoonotic disease anthrax, caused by the endospore-forming bacterium Bacillus anthracis, is very rare in Germany. In the state of Bavaria, the last case occurred in July of 2009, resulting...
9.
Braun P
Int J Clin Pharmacol Ther
. 2022 Feb;
60(3):125-135.
PMID: 35133272
Background: , derived from observational data published by the Robert Koch Institute, Berlin, Germany, is a commonly used parameter to illustrate the course of the COVID-19 pandemic in Germany. The...
10.
Braun P, Zimmermann F, Walter M, Mantel S, Aistleitner K, Sturz I, et al.
mSystems
. 2022 Jan;
7(1):e0136121.
PMID: 35076271
Analysis of 16S rRNA (rRNA) genes provides a central means of taxonomic classification of bacterial species. Based on presumed sequence identity among species of the Bacillus cereus sensu lato group,...